In this study, we provide evidence that the RALB-GTPase is an important regulator of RASMT cancer cell survival and that inhibition of RALB ‘primes’ KRASMT cells to death upon stimulation with DR5-agonistic antibodies. The gene discussed is TNFRSF10B; the disease is cancer.